Delayed	delayed	O	O
leukoencephalopathy	leukoencephalopathy	O	S_disease
with	with	O	O
stroke-like	stroke-like	O	O
presentation	presentation	O	O
in	in	O	O
chemotherapy	chemotherapy	O	O
recipients	recipients	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
A	a	O	O
transient	transient	O	O
leukoencephalopathy	leukoencephalopathy	O	S_disease
mimicking	mimicking	O	O
cerebrovascular	cerebrovascular	O	B_disease
accident	accident	O	I_disease
has	has	O	O
been	been	O	O
described	described	O	O
as	as	O	O
a	a	O	O
complication	complication	O	O
of	of	O	O
chemotherapy	chemotherapy	O	O
,	,	O	O
most	most	O	O
commonly	commonly	O	O
in	in	O	O
recipients	recipients	O	O
of	of	O	O
intrathecal	intrathecal	O	O
methotrexate	methotrexate	S_chemical	O
for	for	O	O
childhood	childhood	O	O
leukaemia	leukaemia	O	O
.	.	O	O

Recently	recently	O	O
published	published	O	O
neuroimaging	neuroimaging	O	O
data	data	O	O
suggest	suggest	O	O
a	a	O	O
common	common	O	O
pathophysiology	pathophysiology	O	O
associated	associated	O	O
with	with	O	O
a	a	O	O
variety	variety	O	O
of	of	O	O
chemotherapy	chemotherapy	O	O
agents	agents	O	O
and	and	O	O
modes	modes	O	O
of	of	O	O
administration	administration	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
We	we	O	O
reviewed	reviewed	O	O
the	the	O	O
medical	medical	O	O
literature	literature	O	O
for	for	O	O
single	single	O	O
reports	reports	O	O
and	and	O	O
case	case	O	O
series	series	O	O
of	of	O	O
patients	patients	O	O
presenting	presenting	O	O
with	with	O	O
stroke-like	stroke-like	O	O
episodes	episodes	O	O
while	while	O	O
receiving	receiving	O	O
systemic	systemic	O	O
or	or	O	O
intrathecal	intrathecal	O	O
chemotherapy	chemotherapy	O	O
.	.	O	O

We	we	O	O
only	only	O	O
included	included	O	O
studies	studies	O	O
providing	providing	O	O
detailed	detailed	O	O
neuroimaging	neuroimaging	O	O
data	data	O	O
.	.	O	O

Patients	patients	O	O
with	with	O	O
cerebrovascular	cerebrovascular	O	O
accidents	accidents	O	O
were	were	O	O
excluded	excluded	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
We	we	O	O
identified	identified	O	O
27	27	O	O
reports	reports	O	O
of	of	O	O
toxic	toxic	O	O
leukoencephalopathy	leukoencephalopathy	O	S_disease
in	in	O	O
patients	patients	O	O
treated	treated	O	O
with	with	O	O
methotrexate	methotrexate	S_chemical	O
(	(	O	O
intrathecal	intrathecal	O	O
,	,	O	O
systemic	systemic	O	O
)	)	O	O
,	,	O	O
5-fluorouracil	5-fluorouracil	S_chemical	O
and	and	O	O
its	its	O	O
derivative	derivative	O	O
carmofur	carmofur	O	O
,	,	O	O
and	and	O	O
capecitabine	capecitabine	S_chemical	O
.	.	O	O

Diffusion	diffusion	O	O
weighted	weighted	O	O
imaging	imaging	O	O
(	(	O	O
DWI	dwi	O	O
)	)	O	O
of	of	O	O
all	all	O	O
patients	patients	O	O
revealed	revealed	O	O
well	well	O	O
demarcated	demarcated	O	O
hyperintense	hyperintense	O	O
lesions	lesions	O	O
within	within	O	O
the	the	O	O
subcortical	subcortical	O	O
white	white	O	O
matter	matter	O	O
of	of	O	O
the	the	O	O
cerebral	cerebral	O	O
hemispheres	hemispheres	O	O
and	and	O	O
the	the	O	O
corpus	corpus	O	O
callosum	callosum	O	O
,	,	O	O
corresponding	corresponding	O	O
to	to	O	O
areas	areas	O	O
of	of	O	O
decreased	decreased	O	O
proton	proton	O	O
diffusion	diffusion	O	O
on	on	O	O
apparent	apparent	O	O
diffusion	diffusion	O	O
coefficient	coefficient	O	O
(	(	O	O
ADC	adc	O	O
)	)	O	O
maps	maps	O	O
(	(	O	O
available	available	O	O
in	in	O	O
21/27	21/27	O	O
patients	patients	O	O
)	)	O	O
.	.	O	O

Lesions	lesions	O	O
exceeded	exceeded	O	O
the	the	O	O
confines	confines	O	O
of	of	O	O
adjacent	adjacent	O	O
vascular	vascular	O	O
territories	territories	O	O
.	.	O	O

Complete	complete	O	O
resolution	resolution	O	O
of	of	O	O
symptoms	symptoms	O	O
within	within	O	O
1	1	O	O
-	-	O	O
4	4	O	O
days	days	O	O
was	was	O	O
accompanied	accompanied	O	O
by	by	O	O
normalisation	normalisation	O	O
of	of	O	O
ADC	adc	O	O
abnormalities	abnormalities	O	O
.	.	O	O

However	however	O	O
,	,	O	O
fluid	fluid	O	O
attenuated	attenuated	O	O
inversion	inversion	O	O
recovery	recovery	O	O
(	(	O	O
FLAIR	flair	O	O
)	)	O	O
sequences	sequences	O	O
frequently	frequently	O	O
revealed	revealed	O	O
persistent	persistent	O	O
white	white	O	O
matter	matter	O	O
abnormalities	abnormalities	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Several	several	O	O
pathophysiological	pathophysiological	O	O
models	models	O	O
of	of	O	O
delayed	delayed	O	O
leukoencephalopathy	leukoencephalopathy	O	S_disease
after	after	O	O
exposure	exposure	O	O
to	to	O	O
intrathecal	intrathecal	O	O
or	or	O	O
systemic	systemic	O	O
chemotherapy	chemotherapy	O	O
have	have	O	O
been	been	O	O
proposed	proposed	O	O
.	.	O	O

DWI	dwi	O	O
findings	findings	O	O
in	in	O	O
this	this	O	O
cohort	cohort	O	O
are	are	O	O
indicative	indicative	O	O
of	of	O	O
cytotoxic	cytotoxic	O	O
oedema	oedema	O	O
within	within	O	O
cerebral	cerebral	O	O
white	white	O	O
matter	matter	O	O
and	and	O	O
lend	lend	O	O
support	support	O	O
to	to	O	O
an	an	O	O
at	at	O	O
least	least	O	O
partially	partially	O	O
reversible	reversible	O	O
metabolic	metabolic	O	O
derangement	derangement	O	O
as	as	O	O
the	the	O	O
basis	basis	O	O
for	for	O	O
this	this	O	O
syndrome	syndrome	O	O
.	.	O	O

